Cellulitis

New England Journal of Medicine

Volumn 350, Issue 9, 2004, Pages 904-912

  Swartz, Morton N ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYLAMINE DERIVATIVE; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CEFOTAXIME; CEFRADINE; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLOTRIMAZOLE; DICLOXACILLIN; IMIDAZOLE DERIVATIVE; LEVOFLOXACIN; LINEZOLID; METICILLIN; MICONAZOLE; MOXIFLOXACIN; NAFCILLIN; OXACILLIN; PENICILLIN DERIVATIVE; PROBENECID; PYRIDONE DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TERBINAFINE; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; BLOOD CULTURE; CASE REPORT; CELLULITIS; CLINICAL FEATURE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ERYTHEMA; FEVER; FOOT PAIN; GRAM POSITIVE BACTERIUM; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUNCH BIOPSY; RADIODIAGNOSIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS; TREATMENT INDICATION; REVIEW;

ADULT; ANTI-BACTERIAL AGENTS; CELLULITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE;

EID: 1342331884     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMcp031807     Document Type: Article

References (50)

1. Barzilai A, Choen HA. Isolation of group A streptococci from children with perianal cellulitis and from their siblings. Pediatr Infect Dis J 1998;17:358-60.
2. Binswanger IA, Kral AH, Blumenthal RN, Rybold DJ, Edlin BR. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Francisco. Clin Infect Dis 2000;30:579-81.
3. Dancer SJ, McNair D, Finn P, Kolsto AB. Bacillus cereus cellulitis from contaminated heroin. J Med Microbiol 2002;51:278-81.
4. Simon MS, Cody RL. Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med 1992;93:543-8.
5. Mertz KR, Baddour LM, Bell JL, Gwin JL. Breast cellulitis following breast conservation therapy: a novel complication of medical progress. Clin Infect Dis 1998;26:481-6.
6. Miller SR, Mondry T, Reed JS, Findley A, Johnstone PA. Delayed cellulitis associated with conservative therapy for breast cancer. J Surg Oncol 1998;67:242-5.
7. Baddour LM, Bisno AL. Non-group A beta-hemolytic streptococcal cellulitis: association with venous and lymphatic compromise. Am J Med 1985;79:155-9.
8. Dupuy A, Benchikhi H, Roujeau JC, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ 1999;318: 1591-4.
9. Woo PCY, Lum, PNL, Wong SSY, Cheng VC, Yuen KY. Cellulitis complicating lymphoedema. Eur J Clin Microbiol Infect Dis 2000;19:294-7.
10. Parada JP, Maslow JN. Clinical syndromes associated with adult pneumococcal cellulitis. Scand J Infect Dis 2000;32:133-6.
11. Porras MC, Martínez VC, Ruiz IM, et al. Acute cellulitis: an unusual manifestation of meningococcal disease. Scand J Infect Dis 2001;33:56-9.
12. Chuang Y-C, Yuan C-Y, Liu C-Y, Lan CK, Huang AH. Vibrio vulnificus infection in Taiwan: report of 28 cases and review of clinical manifestations and treatment. Clin Infect Dis 1992;15:271-6.
13. Fernandez JM, Serrano M, De Arriba JJ, Sanchez MV, Escribano E, Ferreras P, Bacteremic cellulitis caused by non-01, non-0139 Vibrio cholerae: report of a case in a patient with hemochromatosis. Diagn Microbiol Infect Dis 2000;37:77-80.
14. Gach JE, Charles-Holmes R, Ghose A. E. coli cellulitis. Clin Exp Dermatol 2002;27: 523-5.
15. Kiehlbauch JA, Tauxe RV, Baker CN, Wachsmuth IK. Helicobacter cinaedi-associated bacteremia and cellulitis in immunocompromised patients. Ann Intern Med 1994; 121:90-3.
16. Horrevorts AM, Huysmans FTM, Koopman RJJ, Meis JFG. Cellulitis as first clinical presentation of disseminated cryptococcosis in renal transplant recipients. Scand J Infect Dis 1994;26:623-6.
17. Nucci M, Anaissie E. Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 2002;35:909-20.
18. Majeed HA, Quabazard Z, Hijazi Z, Farwana S, Harshani F. The cutaneous manifestations in children with familial Mediterranean fever (recurrent hereditary polyserositis): a six-year study. QJ Med 1990;75: 607-16.
19. Morgan KW, Callen JP. Sweet's syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate of leukemic cells. J Am Acad Dermatol 2001;45:590-5.
20. Sheard RM, Pandey KR, Barnes ND, Vivian AJ. Kawasaki disease presenting as orbital cellulitis. J Pediatr Ophthalmol Strabismus 2000;37:123-5.
21. Taylor GW, Meltzer A. "Inflammatory carcinoma" of the breast. Am J Cancer 1938; 33:33-49.
22. Faber J, Shroeder L, Thill M-P, Jacob F. Carcinoma erysipeloides of the neck. Lancet 2002;359:1025.
23. Stevens DL, Tanner MH, Winship J, et al. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7.
24. Stamenkovic I, Lew PD. Early recognition of potentially fatal necrotizing fasciitis: the use of frozen-section biopsy. N Engl J Med 1984;310:1689-93.
25. Kielhofner MA, Brown B, Dall L. Influence of underlying disease process on the utility of cellulitis needle aspirates. Arch Intern Med 1988;148:2451-2.
26. Sachs MK. The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults. Arch Intern Med 1990; 150:1907-12. [Erratum, Arch Intern Med 1991;151:244.]
27. Sachs MK. The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults. Arch Intern Med 1990; 150:1907-12. [Erratum, Arch Intern Med 1991;151:244.]
28. Duvanel T, Auckenthaler R, Rohner P, Harms M, Saurat JH. Quantitative cultures of biopsy specimens from cutaneous cellulitis. Arch Intern Med 1989;149:293-6.
29. Sigurdsson AF, Gudmundsson S. The etiology of bacterial cellulitis as determined by fine-needle aspiration. Scand J Infect Dis 1989;21:537-42.
30. Hook EW III, Hooton TM, Horton CA, Coyle MB, Ramsey PG, Turck M. Microbiologic evaluation of cutaneous cellulitis in adults. Arch Intern Med 1986;146:295-7.
31. Howe PM, Eduardo Fajardo J, Orcutt MA. Etiologic diagnosis of cellulitis: comparison of aspirates obtained from the leading edge and the point of maximal inflammation. Pediatr Infect Dis J 1987;6:685-6.
32. Grayson ML, Gibbons GW, Habershaw GW, et al. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994;18:683-93. [Erratum, Clin Infect Dis 1994;19:820.]
33. Grayson ML, Gibbons GW, Habershaw GW, et al. Use of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients. Clin Infect Dis 1994;18:683-93. [Erratum, Clin Infect Dis 1994;19:820.]
34. Perl B, Gottehrer NP, Ravek D, Schlesinger Y, Rudensky B, Yinnon AM. Cost-effectiveness of blood cultures for adult patients with cellulitis. Clin Infect Dis 1999;29:1483-8.
35. Schmid MR, Kossmann T, Duewell S. Differentiation of necrotizing fasciitis and cellulitis using MR imaging. AJR Am J Roentgenol 1998;170:615-20.
36. Chao H-C, Lin S-J, Huang Y-C, Lin TY. Sonographic evaluation of cellulitis in children. J Ultrasound Med 2000;19:743-9.
37. Suga K, Ariga M, Motoyama K, Hara A, Kume N, Matsunaga N. Ga-67-avid massive cellulitis: within chronic lymphedematous limb in a survivor of Hodgkin's disease. Clin Nucl Med 2001;26:791-2.
38. Bradsher RW Jr, Snow RM. Ceftriaxone treatment of skin and soft tissue infections in a once daily regimen. Am J Med 1984;77; 63-7.
39. Grayson ML, McDonald M, Gibson K, et al. Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults. Clin Infect Dis 2002;34:1440-8.
40. McKinnon PS, Paladino JA, Grayson ML, Gibbons GW, Karchmer AW. Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threathening foot infections in diabetic patients. Clin Infect Dis 1997;24:57-63.
41. Gentry LO, Ramirez-Ronda CH, Rodriguez-Noriega E, Thadepalli H, del Rosal PL, Ramirez C. Oral ciprofloxacin vs parenteral cefotaxime in the treatment of difficult skin and skin structure infections: a multicenter trial. Arch Intern Med 1989;149;2579-83.
42. Muijsers RB, Jarvis B. Moxifloxacin in of uncomplicated skin and skin structure infections. Drugs 2002;62:967-73.
43. Graham DR, Talan DA, Nichols RL, et al. Once-daily, high-dose levofloxacin versus ticarcilli-clavulanate alone or followed by amoxcillin-clavulanate for complicated skin and skin-structure infections: a randomized, open label trial. Clin Infect Dis 2002;35:381-9.
44. Stevens DL, Smith LG, Bruss, JB, et al. Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections. Antimicrob Agents Chemother 2000;44:3408-13.
45. Stevens DL, Herr D, Lamperis H, Hunt JL, Batts DH, Hafkin B. Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2002;34:1481-90.
46. Liu V, Mackool BT. Current diagnosis and management of chronic fungal infection of the feet and nails. In: Remington JS, Swartz MN, eds. Current clinical topics in infectious diseases. Vol: 19. Malden Mass.: Blackwell Science, 1999:305-26.
47. Groom AV, Wolsey DH, Naimi TS, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001;286:1201-57.
48. Eady EA, Cove JH. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus - an emerging problem for the management of skin and soft tissue infections. Curr Opin Infect Dis 2003;16:103-24.
49. Wang J-H, Liu Y-C, Cheng DL, et al. Role of benzathine penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs. Clin Infect Dis 1997;25:685-9.
50. Kremer M, Zuckerman R, Avraham Z, Long term antimicrobial therapy in the prevention of recurrent soft-tissue infections. J Infect 1991;22:37-40.